R. Oseshnyuk

Experience of determination of antitumor drugs concentrations as a method of providing the safety of pharmacotherapy

Petr D. Shabanov, G. G. Rodionov, I. I. Shantyr, 2018 .

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

M. Stukova, D. Lioznov, R. Oseshnyuk, 2023, Vaccines.

Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19

T. Soluyanova, R. Oseshnyuk, M. Rusanova, 2020, SSRN Electronic Journal.

Efficacy and safety of favipiravir in a complex therapy of mild to moderate COVID-19

T. Soluyanova, R. Oseshnyuk, S. Shcherbak, 2020 .